Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Wright

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
International Journal of Cancer|February 20, 1997
Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosisY Dong, M D Walsh, M A McGuckin, et al.
Anesthesia and Analgesia|March 1, 1981
Enflurane analgesia in obstetricsT K Abboud, S M Shnider, R G Wright, et al.
The Medical Journal of Australia|February 5, 1996
Automated screening of pap smears: a statement of cautionG Medley, C R Laverty, D W Fortune, et al.
Acta Cytologica|August 10, 2000
Quality assurance and risk reduction guidelinesD R Mody, D D Davey, M Branca, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
International Journal of Cancer|February 20, 1997
Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosisY Dong, M D Walsh, M A McGuckin, et al.
Anesthesia and Analgesia|March 1, 1981
Enflurane analgesia in obstetricsT K Abboud, S M Shnider, R G Wright, et al.
The Medical Journal of Australia|February 5, 1996
Automated screening of pap smears: a statement of cautionG Medley, C R Laverty, D W Fortune, et al.
Acta Cytologica|August 10, 2000
Quality assurance and risk reduction guidelinesD R Mody, D D Davey, M Branca, et al.
Pageof 8